UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment cessation in noncirrhotic, e‐antigen negative chronic hepatitis B is safe and effective following prolonged anti‐viral suppression with nucleosides/nucleotides

Alimentary pharmacology & therapeutics, 2014-10, Vol.40 (7), p.804-810

2014

Volltextzugriff (PDF)

The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific

Journal of viral hepatitis, 2011-04, Vol.18 (4), p.e75-e80

2011

Volltextzugriff (PDF)

The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (2), p.255-265

2012

Volltextzugriff (PDF)

Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3

Journal of viral hepatitis, 2013-10, Vol.20 (10), p.669-677

2013

Volltextzugriff (PDF)

Real‐world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study

Journal of viral hepatitis, 2017-01, Vol.24 (1), p.22-27

2017

Volltextzugriff (PDF)

Effectiveness of 8‐ or 12‐weeks of ledipasvir and sofosbuvir in real‐world treatment‐naïve, genotype 1 hepatitis C infected patients

Alimentary pharmacology & therapeutics, 2017-09, Vol.46 (5), p.540-548

2017

Volltextzugriff (PDF)

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

Journal of viral hepatitis, 2013-11, Vol.20 (11), p.745-760

2013

Volltextzugriff (PDF)

Transient elastography for predicting clinical outcomes in patients with chronic liver disease

Journal of viral hepatitis, 2012-02, Vol.19 (2), p.e184-e193

2012

Volltextzugriff (PDF)

A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

Journal of viral hepatitis, 2012-05, Vol.19 (s2), p.1-26

2012

Volltextzugriff (PDF)

Direct costs of first-generation protease inhibitors for the treatment of genotype 1 chronic hepatitis C viral infection

Journal of viral hepatitis, 2015-12, Vol.22 (12), p.974-976

2015

Volltextzugriff (PDF)

An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C

American journal of clinical pathology, 2000-11, Vol.114 (5), p.712-718

2000

Volltextzugriff (PDF)

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus

AIDS (London), 2005-03, Vol.19 (6), p.585-592

2005

Volltextzugriff (PDF)

Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results

Digestive and liver disease, 2004-11, Vol.36 (11), p.752-759

2004

Volltextzugriff (PDF)

Welcome to the new, all electronic Journal of Viral Hepatitis

Journal of viral hepatitis, 2015-01, Vol.22 (1), p.1-1

2015

Volltextzugriff (PDF)

Watchful waiting: role of disease progression on uncertainty and depressive symptoms in patients with chronic Hepatitis C

Journal of viral hepatitis, 2014-10, Vol.21 (10), p.727-733

2014

Volltextzugriff (PDF)

Review article: pharmacological approaches for the treatment of thrombocytopenia in patients with chronic liver disease and hepatitis C infection

Alimentary Pharmacology and Therapeutics, 2007-11, Vol.26 (s1), p.29-39

2007

Volltextzugriff (PDF)

A recombinant bovine gallbladder mucin polypeptide binds biliary lipids and accelerates cholesterol crystal appearance time

Gastroenterology (New York, N.Y. 1943), 1999-04, Vol.116 (4), p.936-942

1999

Volltextzugriff (PDF)

Introduction: thrombocytopenia in chronic liver disease – treatment implications and novel approaches

Alimentary pharmacology & therapeutics, 2007-11, Vol.26 (s1), p.1-4

2007

Volltextzugriff (PDF)

Two-year results of a randomised double-blinded trial evaluating silymarin for chronic hepatitis C

Digestive and liver disease, 2005-07, Vol.37 (7), p.542-543

2005

Volltextzugriff (PDF)

Good cholesterol, bad cholesterol: Role of oxysterols in biliary tract diseases

Gastroenterology (New York, N.Y. 1943), 2001-07, Vol.121 (1), p.216-218

2001

Volltextzugriff (PDF)

Telaprevir for Previously Treated Chronic HCV Infection

The New England journal of medicine, 2010-04, Vol.362 (14), p.1292-1303

2010

Volltextzugriff (PDF)

pH-Dependent Conformational Change of Gastric Mucin Leads to Sol-Gel Transition

Biophysical journal, 1999-03, Vol.76 (3), p.1250-1258

1999

Volltextzugriff (PDF)

Identification of a 130-kilodalton human biliary concanavalin a binding protein as aminopeptidase N

Gastroenterology (New York, N.Y. 1943), 1994-03, Vol.106 (3), p.755-762

1994

Volltextzugriff (PDF)

Evaluation of Liver Fibrosis: A Concise Review

The American journal of gastroenterology, 2004-06, Vol.99 (6), p.1160-1174

2004

Volltextzugriff (PDF)

Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection

The Journal of immunology (1950), 1998-02, Vol.160 (3), p.1479-1488

1998

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(137)

Publikationsform

Artikel
(158)

Sprache

Englisch
(157)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Life Sciences & Biomedicine
(93)
Humans
(79)
Gastroenterology & Hepatology
(57)
Male
(56)
Female
(53)
Middle Aged
(45)
Biological And Medical Sciences
(44)
Adult
(39)
Medical Sciences
(37)
Infectious Diseases
(30)
Hepatitis C, Chronic - Drug Therapy
(27)
Antiviral Agents - Therapeutic Use
(25)
Hepacivirus - Genetics
(22)
Aged
(20)
Gastroenterology. Liver. Pancreas. Abdomen
(19)
Hepatitis C, Chronic - Virology
(19)
Hepatitis
(18)
Animals
(17)
Drug Therapy, Combination
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment cessation in noncirrhotic, e‐antigen negative chronic hepatitis B is safe and effective following prolonged anti‐viral suppression with nucleosides/nucleotides

The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific

The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study

Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3

Real‐world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study

Effectiveness of 8‐ or 12‐weeks of ledipasvir and sofosbuvir in real‐world treatment‐naïve, genotype 1 hepatitis C infected patients

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

Transient elastography for predicting clinical outcomes in patients with chronic liver disease

A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

Direct costs of first-generation protease inhibitors for the treatment of genotype 1 chronic hepatitis C viral infection

An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus

Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results

Welcome to the new, all electronic Journal of Viral Hepatitis

Watchful waiting: role of disease progression on uncertainty and depressive symptoms in patients with chronic Hepatitis C

Review article: pharmacological approaches for the treatment of thrombocytopenia in patients with chronic liver disease and hepatitis C infection

A recombinant bovine gallbladder mucin polypeptide binds biliary lipids and accelerates cholesterol crystal appearance time

Introduction: thrombocytopenia in chronic liver disease – treatment implications and novel approaches

Two-year results of a randomised double-blinded trial evaluating silymarin for chronic hepatitis C

Good cholesterol, bad cholesterol: Role of oxysterols in biliary tract diseases

Telaprevir for Previously Treated Chronic HCV Infection

pH-Dependent Conformational Change of Gastric Mucin Leads to Sol-Gel Transition

Identification of a 130-kilodalton human biliary concanavalin a binding protein as aminopeptidase N

Evaluation of Liver Fibrosis: A Concise Review

Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection

Suchergebnisse filtern